59399-41-6

59399-41-6 structure
59399-41-6 structure
  • Name: Y-9738
  • Chemical Name: Ethyl [2-(4-chlorophenyl)-5-ethoxy-1,3-oxazol-4-yl]acetate
  • CAS Number: 59399-41-6
  • Molecular Formula: C15H16ClNO4
  • Molecular Weight: 309.74500
  • Catalog: Research Areas Cardiovascular Disease
  • Create Date: 2016-02-03 17:48:29
  • Modify Date: 2024-01-10 18:59:57
  • Y-9738 is a hypolipidemic agent.

Name Ethyl [2-(4-chlorophenyl)-5-ethoxy-1,3-oxazol-4-yl]acetate
Synonyms [2-(4-chlorophenyl)-3H-imidazol-4-yl]methanol
ethyl-2-(4-chlorophenyl)-5-ethoxy-4-oxazole acetate
[2-(4-chloro-phenyl)-5-ethoxy-oxazol-4-yl]-acetic acid ethyl ester
ethyl 2-p-chlorophenyl-5-ethoxy-4-oxazoleacetate
Y-9738
Description Y-9738 is a hypolipidemic agent.
Related Catalog
In Vivo Y-9738 is a hypolipidemic agent. At 100 mg/kg Y-9738 lowers the cholesterol level by 36% and clearly diminishes the intensity of the β-lipoprotein band with a tendency for the α-lipoprotein band to be intensified. Y-9738 causes a dose-dependent decrease in serum cholesterol, triglyceride and heparin-precipitable β-lipoprotein cholesterol. Furthermore, Y-9738 reduces the intensity of the β-lipoprotein band shown by electrophoresis, and increases that of the α-lipoprotein band[1].
Animal Admin Male Sprague-Dawley rats are used in this work. Rats (140 to 180 g) are fed a high cholesterol diet for 10 days. This diet contains 1% cholesterol, 0.2% sodium cholate and 5% olive oil. Y-9738 is orally administered to the animals once a day throughout the experimental period. All animals are starved overnight (about 20 h) after the last treatment and sacrificed by carotid incision. Blood and liver are collected for lipid analysis[1].
References

[1]. Kobayakawa T, et al. Experimental hyper-beta-lipoproteinemia and its amelioration by a novel hypolipidemic agent. Atherosclerosis. 1978 Jul;30(3):219-25.

Density 1.226g/cm3
Boiling Point 416.2ºC at 760 mmHg
Molecular Formula C15H16ClNO4
Molecular Weight 309.74500
Flash Point 205.5ºC
Exact Mass 309.07700
PSA 61.56000
LogP 3.49930
Index of Refraction 1.53
Storage condition 2-8℃

~%

59399-41-6 structure

59399-41-6

Literature: Yoshitomi Pharmaceutical Industries, Ltd. Patent: US4012412 A1, 1977 ;